Medical Condition News

RSS

Low level exposure to carbon dioxide leads to increased risk of hospitalization in older people

Exposure to carbon monoxide, even at levels well below national limits, is associated with an increased risk of hospitalization for the elderly with heart problems, according to a study published today in Circulation: Journal of the American Heart Association.

1 Sep 2009

Mitoxantrone is highly efficient in suppressing multiple sclerosis

According to data supplied by the German Multiple Sclerosis Society's national MS register (DMSG - Deutsche Multiple Sklerose Gesellschaft), up to 10% of German MS patients have been treated with mitoxantrone in the past few years.

1 Sep 2009

Patient race more important than blood pressure control status for determining the quality of patient-doctor communication

Black patients with high blood pressure experience poorer communication with their doctors than white patients do, a study led by a University of North Carolina at Chapel Hill researcher has found.

1 Sep 2009

Study reveals that low carbohydrate diet delayed the need for antihyperglycemic drug therapy in type 2 diabetic patients

A study published in Annals of Internal Medicine found that compared with a low-fat diet, a low-carbohydrate Mediterranean-style diet led to more favorable changes in glycemic control and coronary risk factors and delayed the need for antihyperglycemic drug therapy for overweight patients with newly-diagnosed type 2 diabetes.

1 Sep 2009

CLARIFY registry designed to increase knowledge and understanding of CAD was launched in 40 countries

CLARIFY, the largest international registry to ever be carried out in stable coronary artery disease (CAD) patients was launched today in 40 countries, including Canada, at the European Society of Cardiology (ESC) Congress.

31 Aug 2009

MabCure featured in the August edition of Biotechnology Focus magazine

MabCure, Inc. (“MabCure”), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, has been featured in the August edition of Biotechnology Focus, Canada's oldest and most successful magazine serving the Canadian life science industry.

31 Aug 2009

Health Net urges Americans to have their blood cholesterol measured

Tomorrow, September 1, marks the start of National Cholesterol Education Month. In support of this educational effort, Health Net, Inc., (NYSE: HNT) is encouraging those who haven't yet done so, to have their blood cholesterol measured and, if it's high, to embark on a cholesterol-lowering program.

31 Aug 2009

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

PsychoGenics Inc. and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System (CNS) disorders.

31 Aug 2009

DYSlipidemia International Study results presented at the ESC congress

According to a new analysis of 22,000 patients, nearly three-quarters of patients taking statins still had at least one lipid abnormality. These results, from a study conducted by Merck & Co., Inc., Whitehouse Station, N.J., U.S.A., which operates in many countries as Merck Sharp & Dohme Limited, were presented today at the European Society of Cardiology (ESC) congress in Barcelona, Spain.

31 Aug 2009

Doxorubicin granted orphan drug designation by the FDA

Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.

31 Aug 2009

Varian Medical Systems unveils first low-energy radiotherapy system with image-guidance and RapidArc treatment capabilities

Varian Medical Systems is introducing the world's first low-energy radiotherapy system with image-guidance and RapidArc treatment capabilities for international cancer clinics. Varian's UNIQUE(TM) radiotherapy system is expected to make advanced care more affordable and more widely available to cancer patients around the world.

31 Aug 2009

Caltech neuroscientists emphasize on the neural mechanisms involved in social behaviour

In a finding that sheds new light on the neural mechanisms involved in social behavior, neuroscientists at the California Institute of Technology (Caltech) have pinpointed the brain structure responsible for our sense of personal space.

30 Aug 2009

American Podiatric Medical Association refutes Arizona Congressman's statement

In an interview this week with FOX News' Neil Cavuto, Congressman John Shadegg (R-AZ) said podiatry was an "esoteric demand that most people don't have or don't need," during a discussion on health care reform.

29 Aug 2009

Inhibitor Education Summits to address pertinent topics regarding hemophilia

More than 160 families of patients living with a rare form of hemophilia are coming together at educational summits sponsored this fall by the National Hemophilia Foundation (NHF) and the Center for Biomedical Continuing Education (CBCE). For the fifth year, the Inhibitor Education Summits will connect patients and their families with expert healthcare professionals and fellow patients to address pertinent topics such as effective pain management, exercise and nutrition, financial security, and psychological wellbeing.

29 Aug 2009

High dosage of ursodeoxycholic acid does not help PSC patients

A national team of researchers led by scientists at Mayo Clinic has found that a common treatment for primary sclerosing cholangitis, a chronic liver disease, is not helpful for patients, according to a study published this month in the journal Hepatology.

29 Aug 2009

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

28 Aug 2009

Milestone reached in Biotie Wyeth collaboration for the development of PDE10 inhibitors for schizophrenia

Biotie announced today that it has reached a milestone in its collaboration with Wyeth for the development of PDE10 (phosphodiesterase 10) inhibitors for schizophrenia, triggering a USD 1.0 million milestone payment to Biotie.

28 Aug 2009

The Research Partnership study reveals that diabetes can have a major effect on people's lives

A new research study carried out by The Research Partnership reveals that living with diabetes can have a major effect on people's lives, with just under half (44%) of type 2 patients reporting that the condition has impacted on either their ability or their desire to have sex.

28 Aug 2009

Iowa researchers modify siRNA for impacting targeted cells in cancer treatment

Small interfering RNA (siRNA), a type of genetic material, can block potentially harmful activity in cells, such as tumor cell growth. But delivering siRNA successfully to specific cells without adversely affecting other cells has been challenging.

28 Aug 2009

Springer signs agreement with The Endocrine Society to co-publish a new journal

Springer, one of the leading publishers in the fields of science, technology and medicine, has signed an agreement with The Endocrine Society to co-publish a new journal, Hormones & Cancer, starting in January 2010.

28 Aug 2009

Medical Condition News

Low level exposure to carbon dioxide leads to increased risk of hospitalization in older people

Mitoxantrone is highly efficient in suppressing multiple sclerosis

Patient race more important than blood pressure control status for determining the quality of patient-doctor communication

Study reveals that low carbohydrate diet delayed the need for antihyperglycemic drug therapy in type 2 diabetic patients

CLARIFY registry designed to increase knowledge and understanding of CAD was launched in 40 countries

MabCure featured in the August edition of Biotechnology Focus magazine

Health Net urges Americans to have their blood cholesterol measured

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

DYSlipidemia International Study results presented at the ESC congress

Doxorubicin granted orphan drug designation by the FDA

Varian Medical Systems unveils first low-energy radiotherapy system with image-guidance and RapidArc treatment capabilities

Caltech neuroscientists emphasize on the neural mechanisms involved in social behaviour

American Podiatric Medical Association refutes Arizona Congressman's statement

Inhibitor Education Summits to address pertinent topics regarding hemophilia

High dosage of ursodeoxycholic acid does not help PSC patients

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

Milestone reached in Biotie Wyeth collaboration for the development of PDE10 inhibitors for schizophrenia

The Research Partnership study reveals that diabetes can have a major effect on people's lives

Iowa researchers modify siRNA for impacting targeted cells in cancer treatment

Springer signs agreement with The Endocrine Society to co-publish a new journal

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Latest News